Overview

Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the current study is to assess the safety and tolerability of intravenous tonapofylline.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Biogen
Treatments:
1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine